Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
Introduction: Neuroendocrine tumors originate from neuroendocrine cells. Clinicians diagnose and track these tumors not only but also by analysing patients' blood for biomarkers. Including liquid biopsy in early detection and monitoring can improve patient outcomes.
Conference:
Presenting Author:
Authors: Pachnikova G, Jann H, Tacke F, Keilholz U,
Keywords: liquid biopsy, circulating tumor cells, cell-free DNA, neuroendocrine tumor, case study, copy number variations,
Introduction: Non-functional pancreatic neuroendocrine tumors (NF-PanNETs) displayed heterogeneous prognoses. Copy number variations (CNVs) of ADAM15 significantly increased in patients who underwent postoperative early recurrence. ADAM15 (a disintegrin and metalloproteinase 15) has been identified as a key molecule in progression and metastasis of many tumors, regulating immune infiltration. However, correlation between ADAM15 and NF-PanNETs remains unknown.
Conference:
Presenting Author:
Authors: Tang L, Ying Y, Peng M, Wang Y, Lou W,
Keywords: pancreatic neuroendocrine tumor, recurrence, metastasis, ADAM15, tumor-infiltrating neutrophils,
#3392 The chromosome 18 loss of heterozygosity axis of small intestinal neuroendocrine tumors
Introduction: Small intestinal neuroendocrine tumors (siNETs) are rare neoplasms which have low mutational burdens: With subtypes characterised in terms of copy number variation (CNV). Subtypes are defined as: Chromosome 18 loss of heterozygosity (18LOH), multiple copy number variation (MultiCNV), or no copy number variations (NoCNV). 18LOH tumors are associated with improved outcomes, the reasons for which are poorly understood.
Conference:
Presenting Author: Waterfield S
Authors: Waterfield S, Yousefi P, Amaulu A, Relton C, Thirlwell C,
Keywords: neuroendocrine, small intestinal, methylation, epigenetics, omics,
Introduction: Pancreatic neuroendocrine tumors (PNETs) are potentially lethal diseases that show variable degrees of proliferation and invasiveness. Although genetic subgroups have been suggested to give prognostic information the impact of clonal evolution to the development and outcome of PNETs remains unexplored.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Crona J
Authors: Crona J, Backman S, Kugelberg J, Maharjan R, Björklund P,
Keywords: Cancer evolution, Molecular genetics, Neuroendocrine Tumor,
Our website automatically sets cookies, which are technically necessary for the operation of the website. By clicking "OK", Google Analytics and the associated cookies are also activated for the purpose of website analysis and optimization. Detailed Information and the possibility to revoke your consent at any time, you can find in our privacy policy.
These cookies are so-called "session cookies." They are automatically deleted after your visit.
Protects you from Cross-Site-Request-Forgery attacks.
Saves the current PHP session.
For webinar purposes, ENETS uses VIMEO as an embedded iframe on MY ENETS. VIMEO implements its own tracking system, which is beyond the of ENETS responsibility. By watching ENETS videos on the ENETS website, you also agree to the conditions of VIMEO: https://vimeo.com/privacy
This website uses Google Analytics, a web analytics service. It is operated by Google Inc., 1600 Amphitheatre Parkway, Mountain View, CA 94043, USA. Google Analytics cookies are stored based on your consent Art. 6 (1) (a) DSGVO/GDPR, which we confirm via the consent banner.
For more information about how Google Analytics handles user data, see Google's privacy policy: https://support.google.com/analytics/answer/6004245?hl=en.